Chevallard Daniel R.
Officer at VIRX; Chief Financial Officer at Regulus Therapeutics Inc.
- Sold, on record
- $120k
- Dollars the filings state
- Form 4 sales
- 13
- Latest Feb 27, 2024
- Form 144 notices
- 2
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- VIRXViracta Therapeutics, Inc.Officer
- Regulus Therapeutics Inc.Chief Financial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- VIRX40,231 shares
- Regulus Therapeutics Inc.15,922 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale VIRXPlan not statedNov 28, 2022 2022
Sold 3,532 shares at $2.72 ($10k)
Chevallard Daniel R., CFO and COO
Sold 4% of holdings ($243k position)85,733 shares left0.9x usual sizeFiling
- 2 Form 4 sale VIRXPlan not statedFeb 27, 2023 +91 days
Sold 3,599 shares at $1.68 ($6k)
Chevallard Daniel R., CFO and COO
Sold 3.9% of holdings ($156k position)89,023 shares left1x usual sizeFiling
- 3 Form 4 sale VIRXNo planMay 25, 2023 +87 days
Sold 3,635 shares at $1.42 ($5k)
Chevallard Daniel R., CFO and COO
No 10b5-1 planSold 3.8% of holdings ($136k position)92,277 shares left1x usual sizeFiling
- 4 Form 144 notice VIRXNoticeMay 26, 2023 +1 day
Filed to sell 3,635 shares ($5k)
Chevallard Daniel R., Officer
No 10b5-1 plan1x usual sizeFiling
- 5 Form 4 sale VIRXNo planAug 28, 2023 +94 days
Sold 3,512 shares at $1.45 ($5k)
Chevallard Daniel R., CFO and COO
No 10b5-1 planSold 3.5% of holdings ($144k position)95,653 shares left1x usual sizeFiling
- 6 Form 4 sale VIRXNo planNov 28, 2023 +92 days
Sold 3,720 shares at $0.50 ($2k)
Chevallard Daniel R., CFO and COO
No 10b5-1 planSold 3.6% of holdings ($51k position)98,822 shares left1x usual sizeFiling
- 7 Form 4 sale VIRXNo planFeb 27, 2024 +91 days
Sold 3,405 shares at $0.73 ($2k)
Chevallard Daniel R., CFO and COO
No 10b5-1 planSold 3.2% of holdings ($77k position)102,306 shares left0.9x usual sizeFollows a Form 144Filing
- 8 Form 144 notice VIRXNoticeFeb 27, 2024 same day
Filed to sell 3,405 shares ($2k)
Chevallard Daniel R., Officer
No 10b5-1 plan0.9x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (15)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2024 | Feb 27, 2024 | VIRX | Officer | Form 144 notice | 3,405 | $2k | Notice | SEC | |
| Feb 27, 2024 | Feb 27, 2024 | VIRX | CFO and COO | Form 4 sale | 3,405 | $2k | 3.2% | No plan | SEC |
| Nov 28, 2023 | Nov 28, 2023 | VIRX | CFO and COO | Form 4 sale | 3,720 | $2k | 3.6% | No plan | SEC |
| Aug 28, 2023 | Aug 29, 2023 | VIRX | CFO and COO | Form 4 sale | 3,512 | $5k | 3.5% | No plan | SEC |
| May 26, 2023 | May 26, 2023 | VIRX | Officer | Form 144 notice | 3,635 | $5k | Notice | SEC | |
| May 25, 2023 | May 26, 2023 | VIRX | CFO and COO | Form 4 sale | 3,635 | $5k | 3.8% | No plan | SEC |
| Feb 27, 2023 | Feb 28, 2023 | VIRX | CFO and COO | Form 4 sale | 3,599 | $6k | 3.9% | Plan not stated | SEC |
| Nov 28, 2022 | Nov 29, 2022 | VIRX | CFO and COO | Form 4 sale | 3,532 | $10k | 4.0% | Plan not stated | SEC |
| Aug 26, 2022 | Aug 29, 2022 | VIRX | CFO and COO | Form 4 sale | 3,655 | $15k | 4.2% | Plan not stated | SEC |
| May 26, 2022 | May 27, 2022 | VIRX | CFO and COO | Form 4 sale | 3,596 | $7k | 4.3% | Plan not stated | SEC |
| Feb 28, 2022 | Mar 1, 2022 | VIRX | CFO and COO | Form 4 sale | 3,998 | $11k | 5.0% | Plan not stated | SEC |
| Nov 29, 2021 | Nov 29, 2021 | VIRX | CFO and COO | Form 4 sale | 7,579 | $36k | 9.4% | Plan not stated | SEC |
| Jul 1, 2019 | Jul 2, 2019 | Regulus Therapeutics Inc. | Chief Financial Officer | Form 4 sale | 2,669 | $3k | 3.3% | Plan not stated | SEC |
| May 15, 2019 | May 16, 2019 | Regulus Therapeutics Inc. | Chief Financial Officer | Form 4 sale | 10,000 | $14k | 11.0% | Plan not stated | SEC |
| Apr 1, 2019 | Apr 3, 2019 | Regulus Therapeutics Inc. | Chief Financial Officer | Form 4 sale | 3,253 | $3k | 25.8% | Unusual | SEC |